NCT00556842

Brief Summary

Each year, hip fracture, an injury that can impair independence and quality of life, occurs in about 280,000 Americans and 36,000 Canadians. By the year 2040, the annual healthcare costs associated with hip fractures are expected to reach $9.8 billion in the United States and $650 million in Canada. It is important to have in place optimal practice guidelines for the surgical handling of this injury. One type of hip fracture, called a displaced femoral neck fracture, is often treated with a hip replacement surgery. Patients undergoing a hip replacement may receive either a total hip replacement, in which the head of the femur and the hip joint socket are replaced, or a partial hip replacement, in which only the head of the femur is replaced. This study will compare the two different hip replacement procedures to determine which one results in better outcomes after surgery in adults aged 50 and older.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,495

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2009

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 12, 2007

Completed
1.3 years until next milestone

Study Start

First participant enrolled

March 1, 2009

Completed
10.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2019

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

July 7, 2020

Completed
Last Updated

July 7, 2020

Status Verified

November 1, 2019

Enrollment Period

10.3 years

First QC Date

November 9, 2007

Results QC Date

November 25, 2019

Last Update Submit

June 19, 2020

Conditions

Keywords

Hemi-ArthroplastyTotal Hip Arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Revision Surgery

    The primary outcome is any unplanned secondary procedure within 2 years of the initial joint replacement surgery.

    Measured 2 years after original surgery

Secondary Outcomes (5)

  • Hip Function and Pain

    Measured 2 years after original surgery

  • Number of Participants With Functional Mobility Problems

    Measured 2 years after original surgery

  • Health-Related Quality of Life (SF-12)

    Measured 2 years after original surgery

  • Health-Related Quality of Life (EQ-5D)

    Measured 2 years after original surgery

  • Complications, Including Mortality, Dislocation, Infection, Femoral Fracture, Deep Venous Thrombosis, and Prosthesis Loosening

    Measured 2 years after original surgery

Study Arms (2)

1

ACTIVE COMPARATOR

Participants will undergo total hip arthroplasty.

Device: Total hip arthroplasty

2

ACTIVE COMPARATOR

Participants will undergo hemi-arthroplasty.

Device: Hemi-arthroplasty

Interventions

Proscribed approaches will include minimally invasive total hip arthroplasty (i.e., two incision approaches) and hinged prostheses or capture cups. Other surgical approach aspects, the use of cemented components, the implant manufacturer, and femoral head size will not be standardized. Surgeons will use the manufacturers' specific implant guidelines for insertion.

Also known as: THA
1

Surgeons will use modern implants for hemi-arthroplasty, excluding non-modular, non-canal filling unipolar implants such as Moore's and Thompson's prostheses. The choice of modular unipolar versus bipolar hemi-arthroplasty will not be standardized. Whether implants are inserted with cement or a press-fit design will also not be standardized. Surgeons will use the manufacturers' specific implant guidelines for insertion.

Also known as: HA
2

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult men or women aged 50 years and old (with no upper age limit)
  • Fracture of the femoral neck, as confirmed with either anteroposterior or lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI)
  • Displaced fracture that is not, in the judgment of the attending surgeon, optimally managed by reduction and internal fixation
  • Operative treatment is planned within 72 hours of the patient being medically cleared for surgery
  • Patient was ambulatory prior to the fracture, though they may have used an aid such as a cane or a walker
  • Anticipated medical optimization for arthroplasty of the hip
  • Provision of informed consent by patient or proxy
  • Low energy fracture (defined as a fall from standing height), with no other trauma
  • Assurance from site that surgeons with expertise in both total hip arthroplasty and hemi-arthroplasty are available to perform surgery (Note: Surgeons do not need to be experts in both techniques)

You may not qualify if:

  • Not suitable for hemi-arthroplasty (i.e., inflammatory arthritis, rheumatoid arthritis, pathologic fractures (secondary to cancer), or severe osteoarthritis of the hip)
  • Associated major injuries of the lower extremity (e.g., ipsilateral or contralateral fractures of the foot, ankle, tibia, fibula, knee, or femur; dislocations of the ankle, knee, or hip; or femoral head defects or fracture)
  • Retained hardware around the affected hip that will interfere with arthroplasty
  • Infection around the hip (soft tissue or bone)
  • Bone metabolism disorder except osteoporosis (e.g., Paget's disease, renal osteodystrophy, osteomalacia)
  • Patients with a previous history of frank dementia that would interfere with the assessment of primary outcome (e.g., secondary procedures at 2 years).
  • Likely problems, in the judgment of the investigators, with maintaining follow-up (e.g., no fixed address, plans to move out of town in the next year, or intellectually challenged and without adequate family support)
  • Enrolled in another ongoing drug or surgical intervention trial
  • Patients whose fracture occurred as a result of violence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

New York University Medical Center

New York, New York, 10003, United States

Location

McMaster University

Hamilton, Ontario, L8S4L8, Canada

Location

Related Publications (6)

  • Hebert-Davies J, Laflamme GY, Rouleau D; HEALTH and FAITH investigators. Bias towards dementia: are hip fracture trials excluding too many patients? A systematic review. Injury. 2012 Dec;43(12):1978-84. doi: 10.1016/j.injury.2012.08.061. Epub 2012 Sep 19.

    PMID: 22999009BACKGROUND
  • Burgers PT, Van Geene AR, Van den Bekerom MP, Van Lieshout EM, Blom B, Aleem IS, Bhandari M, Poolman RW. Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures in the healthy elderly: a meta-analysis and systematic review of randomized trials. Int Orthop. 2012 Aug;36(8):1549-60. doi: 10.1007/s00264-012-1569-7. Epub 2012 May 24.

    PMID: 22623062BACKGROUND
  • Burgers PT, Hoogendoorn M, Van Woensel EA, Poolman RW, Bhandari M, Patka P, Van Lieshout EM; HEALTH Trial Investigators. Total medical costs of treating femoral neck fracture patients with hemi- or total hip arthroplasty: a cost analysis of a multicenter prospective study. Osteoporos Int. 2016 Jun;27(6):1999-2008. doi: 10.1007/s00198-016-3484-z. Epub 2016 Jan 28.

    PMID: 26821137BACKGROUND
  • Bhandari M, Devereaux PJ, Einhorn TA, Thabane L, Schemitsch EH, Koval KJ, Frihagen F, Poolman RW, Tetsworth K, Guerra-Farfan E, Madden K, Sprague S, Guyatt G; HEALTH Investigators. Hip fracture evaluation with alternatives of total hip arthroplasty versus hemiarthroplasty (HEALTH): protocol for a multicentre randomised trial. BMJ Open. 2015 Feb 13;5(2):e006263. doi: 10.1136/bmjopen-2014-006263.

    PMID: 25681312BACKGROUND
  • Burgers PT, Poolman RW, Van Bakel TM, Tuinebreijer WE, Zielinski SM, Bhandari M, Patka P, Van Lieshout EM; HEALTH and FAITH Trial Investigators. Reliability, validity, and responsiveness of the Western Ontario and McMaster Universities Osteoarthritis Index for elderly patients with a femoral neck fracture. J Bone Joint Surg Am. 2015 May 6;97(9):751-7. doi: 10.2106/JBJS.N.00542.

    PMID: 25948522BACKGROUND
  • HEALTH Investigators; Bhandari M, Einhorn TA, Guyatt G, Schemitsch EH, Zura RD, Sprague S, Frihagen F, Guerra-Farfan E, Kleinlugtenbelt YV, Poolman RW, Rangan A, Bzovsky S, Heels-Ansdell D, Thabane L, Walter SD, Devereaux PJ. Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture. N Engl J Med. 2019 Dec 5;381(23):2199-2208. doi: 10.1056/NEJMoa1906190. Epub 2019 Sep 26.

MeSH Terms

Conditions

Hip FracturesFemoral Neck Fractures

Interventions

Arthroplasty, Replacement, HipHemiarthroplasty

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Limitations and Caveats

Patients and end-point assessors were unblinded in the assessments of function. Loss to follow-up was 14.9% for the final analysis. Data on function were incomplete; 82.9% of patients completed at least one questionnaire over 24 months.

Results Point of Contact

Title
Paula McKay
Organization
The Centre for Evidence-Based Orthopaedics

Study Officials

  • Mohit Bhandari, MD PhD FRCSC

    McMaster University

    PRINCIPAL INVESTIGATOR
  • Thomas A. Eihnorn, MD

    Boston University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2007

First Posted

November 12, 2007

Study Start

March 1, 2009

Primary Completion

May 30, 2019

Study Completion

May 30, 2019

Last Updated

July 7, 2020

Results First Posted

July 7, 2020

Record last verified: 2019-11

Locations